ZB
IMUX icon

Zions Bancorporation’s Immunic IMUX Stock Holding History

Zions Bancorporation’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6
Closed -$7K – 1064
2017
Q2 		$7K Hold
6
– – ﹤0.01% 378
2017
Q1 		$10K Hold
6
– – ﹤0.01% 368
2016
Q4 		$11K Hold
6
– – ﹤0.01% 484
2016
Q3 		$15K Hold
6
– – ﹤0.01% 422
2016
Q2 		$16K Buy
+6
New +$19.7K ﹤0.01% 373

Other funds holding IMUX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zions Bancorporation's IMUX Position: Q3 2017 in Review

Zions Bancorporation sold out of Immunic (IMUX) in Q3 2017, closing a stake of 6 shares — an estimated $7K sold.

Zions Bancorporation first reported a position in IMUX in Q2 2016 and held it in 5 quarters. The position peaked at $16K in Q2 2016. 42 funds tracked by Wall St. Rank hold IMUX as of Q3 2017.

  • Zions Bancorporation reported no remaining Immunic position as of Q3 2017 after selling out during the quarter.
  • Zions Bancorporation sold 6 Immunic shares in Q3 2017, an estimated $7K.
  • Zions Bancorporation first reported a position in Immunic in Q2 2016 and held it in 5 quarters.
  • Zions Bancorporation's Immunic position peaked at $16K in Q2 2016.
  • 42 funds tracked by Wall St. Rank held Immunic as of Q3 2017.

Based on Zions Bancorporation's 13F filing for Q3 2017, filed 14 Nov 2017.